- MCI Onehealth (DRDR) announced that its subsidiary, Khure Health, has expanded into the American healthcare market
- Khure Health is now offering its AI-enabled clinical intelligence technology and services to healthcare practitioners in the U.S
- It has recently signed its first U.S. contract with one of the largest private nephrology practices in the southern U.S
- MCI is a healthcare technology company which focuses on improving primary care
- MCI Onehealth Technologies Inc. (DRDR) remains unchanged, trading at C$0.61 per share at 12:26 pm ET
MCI Onehealth (DRDR) announced that its subsidiary, Khure Health, has expanded into the American healthcare market.
Khure Health is now offering its AI-enabled clinical intelligence technology and services to healthcare practitioners in the U.S. It has recently signed its first U.S. contract with one of the largest private nephrology practices in the southern U.S. This nephrology practice comprises over 25 outpatient clinics and more than 40 dialysis centers.
The agreement started generating revenue in Q4 2022 via an associated agreement with a large, established top-10 global pharmaceutical company. The agreement will allow Khure Health to showcase its clinical data insights capabilities in a specialist healthcare setting. It will enable further clinical research and data insights partnerships with life sciences companies.
Dr. Alexander Dobranowski, CEO of MCI Onehealth, commented on the news.
“This is a major step for MCI to have Khure Health provide its technology and services in the US market. At the core of Khure’s growth success is its partnerships with physicians in delivering personalized patient care and the pharmaceutical industry in helping to innovate its model to bring more value to physicians. It’s no secret the US healthcare, and life sciences market is the largest in the world. We are planning for significantly accelerated growth in MCI’s higher-margin, data-driven and clinical research initiatives.”
Khure Health’s mission is to help physicians identify rare and complex diseases earlier in their progression to end suffering and save lives. Khure’s AI-enabled clinical intelligence platform allows healthcare practitioners to utilize the vast amounts of valuable clinical data sitting idle in their electronic health records to help identify potential opportunities to improve patient care and create healthcare system efficiencies for all stakeholders. Khure’s offering is part of MCI’s growing suite of data-driven solutions.
MCI is a healthcare technology company which focuses on improving primary care. It aims to empower patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs.
MCI Onehealth Technologies Inc. (DRDR) remains unchanged, trading at C$0.61 per share at 12:26 pm ET.
